Results 201 to 210 of about 144,967 (257)

Evidence Gaps in Prediction Tools for Follow Up After Localised Melanoma

Australasian Journal of Dermatology, EarlyView.
Deonna M. Ackermann, Xu Huang, Ellie Medcalf, Katy J. L. Bell   +3 more
wiley   +1 more source

Minimal residual disease–guided ibrutinib and venetoclax in patients with chronic lymphocytic leukaemia and complex karyotype

British Journal of Haematology, EarlyView.
Minimal residual disease (MRD)–guided ibrutinib and venetoclax (IVen) achieved durable remissions and high undetectable MRD (uMRD) rates in patients with high‐risk chronic lymphocytic leukaemia (CLL). Compared with historical ibrutinib monotherapy, IVen was associated with improved progression‐free and overall survival despite presence of complex ...
Maria Kislova, Elena Dmitrieva, Elena Naumova, Margarita Pochtar, Svetlana Lugovskaya, Yury Kobzev, Alla Loban, Maria Gladysheva, Tatiana Obukhova, Bella Biderman, Andrey Sudarikov, Egor Volchkov, Maria Ivanova, Vadim Ptushkin, Andrea Visentin, Eugene Nikitin   +15 more
wiley   +1 more source

A Non-Pharmacological Approach to Hip Osteoarthritis-Related Pain: A Case Report. [PDF]

Cureus
Chantasirivisal A, Lai IN, Tan QT, Chu G.   +3 more
europepmc   +1 more source

Reduced‐dose versus standard‐dose total body irradiation before allogeneic haematopoietic stem cell transplantation in adults with acute lymphoblastic leukaemia

British Journal of Haematology, EarlyView.
Summary Comparative data on reduced‐dose (8 Gy) versus standard‐dose (12 Gy) total body irradiation (TBI) before allogeneic haematopoietic stem cell transplantation (allo‐HSCT) for adults with acute lymphoblastic leukaemia (ALL) remain limited. We retrospectively analysed 101 adults undergoing first allo‐HSCT between 1999 and 2024 after 8 Gy or 12 Gy ...
Isabella Gruber, Matthias Edinger, Hendrik Poeck, Elisabeth Meedt, Ernst Holler, Wolfgang Herr, Oliver Koelbl, Daniel Wolff   +7 more
wiley   +1 more source

<i>Phytophthora agathidicida</i> was undetected in a pilot survey of soils outside the host's ( <i>Agathis australis</i> ) natural range. [PDF]

MicroPubl Biol
Hadlow IC, Palmer JT, Gerth ML.
europepmc   +1 more source

Chemoproteomic discovery of a brain‐penetrant, covalent NLRP3 inhibitor that binds a novel allosteric pocket

British Journal of Pharmacology, EarlyView.
NLRP3 is a promising inflammatory target, but existing inhibitors lack diversity and brain penetrance, and none are approved. Using chemoproteomics, we discovered a novel series that binds to Cys463 in a previously uncharacterized pocket. Compounds showed nanomolar potency, brain exposure, and in vivo suppression of IL‐1β, supporting neuroinflammatory ...
Donald C. Rogness, Evelyn P. Sievert, Vincent F. Vartabedian, Steffen M. Bernard, Erick Aitchison, William Tao, Mikaela Lindvall, Jing Qian, Christie L. Eissler, Brian E. Nordin, Benjamin D. Horning, Cian Kingston, Kelsey N. Lamb, Joshua C. Bell, Bingwen Lu, Jonathan Pollock, Jun Shi, Roli Khattri, David S. Weinstein, Matthew P. Patricelli, Brian N. Cook, Gabriel M. Simon   +21 more
wiley   +1 more source

Missed Wrist Septic Arthritis: A Cautionary Case Report in a Postpartum Patient With Complement Deficiency. [PDF]

Cureus
Bozzo I, Tremblay D, Harvey EJ, Tsang J.
europepmc   +1 more source

‘I Really Felt Like They Made the Decision Without Involving Me at All’: Young People's Perspectives on Participation in Foster Care Matching in Sweden

Child &Family Social Work, EarlyView.
ABSTRACT This study investigates young people's experiences of participation in the matching process when placed in foster care. Matching is the process by which the social services select a foster home for an individual child. The aim of the study is to highlight participation in the matching process from the young people's perspective.
Kitty Lassinantti, Anna‐Lena Almqvist
wiley   +1 more source

Complete Genome Sequence of <i>Rhodococcus equi</i> Phage Nova53. [PDF]

MicroPubl Biol
Cornwell RE, DeJonge IR, Liang MH, Puzemis AN, Casipit AL, Clement AL, Cooper SJ, Ferreira DB, Halliwill GJ, Koetje JD, Sprick GD, Wallace SJ, Woolworth EM, Radersma MD, Wertz JT, DeJong RJ.   +15 more
europepmc   +1 more source

Depicting the Immunological Landscape of Basal Cell Carcinoma Subtypes

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Background Anti‐PD‐1 response has been associated with higher PD‐1 ligand (PD‐L1) expression levels in different cancer types. Cemiplimab, an anti‐PD‐1 antibody, has been shown to induce a response rate of 31% and 22% in patients with locally advanced basal cell carcinoma (BCC) and metastatic BCC respectively, who have progressed or are ...
Isabella Dommann, Gaetana Restivo, Isabel Kolm, Federica Sella, Patrick Turko, Phil F. Cheng, Mitchell Levesque, Corina Dommann‐Scherrer, Reinhard Dummer, Egle Ramelyte   +9 more
wiley   +1 more source